Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 23, 2026 · 9:30 AM EDT

Mosaic ImmunoEngineering (CPMV) Gains from Investment Securities (2010 - 2023)

Updated

Analysis

Mosaic ImmunoEngineering (CPMV) Gains from Investment Securities (2010 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Mosaic ImmunoEngineering 434,528.21 345,490.21 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 33,900.00
Mar 31, 2023 12,800.00
Dec 31, 2022 -400.00
Sep 30, 2022 56,700.00
Jun 30, 2022 800.00
Mar 31, 2022 500.00
Jun 30, 2021 -20,800.00
Nov 30, 2013 -347.00
Aug 31, 2012 55,873.00
May 31, 2012 268,394.00
Feb 29, 2012 40,054.00
Aug 31, 2011 39,005.00
May 31, 2011 1.20 Mn
Feb 28, 2011 47,860.00
Aug 31, 2010 648,740.00
API Access

Mosaic ImmunoEngineering Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CPMV&period=max&api_key=YOUR_API_KEY